Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 4MSD SUB MERCK

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
BioProcess International US West
Not Confirmed
arrow
BioProcess International US West
Not Confirmed

ERTUGLIFLOZIN; METFORMIN HYDROCHLORIDE

US Patent Number : 9439902

Drug Substance Claim :

Drug Product Claim :

Application Number : 209806

Patent Use Code : U-2214

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2030-10-21

blank

02

arrow
BioProcess International US West
Not Confirmed
arrow
BioProcess International US West
Not Confirmed

ERTUGLIFLOZIN; METFORMIN HYDROCHLORIDE

US Patent Number : 9439902

Drug Substance Claim :

Drug Product Claim :

Application Number : 209806

Patent Use Code : U-2214

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2030-10-21

blank

03

arrow
BioProcess International US West
Not Confirmed
arrow
BioProcess International US West
Not Confirmed

ERTUGLIFLOZIN; METFORMIN HYDROCHLORIDE

US Patent Number : 9439902

Drug Substance Claim :

Drug Product Claim :

Application Number : 209806

Patent Use Code : U-2214

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2030-10-21

blank

04

arrow
BioProcess International US West
Not Confirmed
arrow
BioProcess International US West
Not Confirmed

ERTUGLIFLOZIN; METFORMIN HYDROCHLORIDE

US Patent Number : 9439902

Drug Substance Claim :

Drug Product Claim :

Application Number : 209806

Patent Use Code : U-2214

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2030-10-21

blank